As for testosterone; you understand how important testosterone is to the human body; in-fact, it is one of the most important hormones we produce. Through the use of anabolic steroids our natural testosterone production is suppressed and while total suppression varies with each and every steroid, Nandrolone steroids have a 100% suppression rating. Without testosterone supplementation your body will not have the testosterone it needs to function properly; no matter how special you believe you may be or what your friend may have told you, if you supplement with a Nandrolone hormone you wont be making any testosterone. It is important to note when Deca 300 use comes to and end and once it and any other anabolic steroids have cleared your system your natural testosterone production will begin again; however, during the actual cycle it will not exist. By supplementing with exogenous testosterone we eliminate this problem, we provide our body with the testosterone it needs to function and as a bonus only enhance our Deca 300 use as the testosterone hormone in of itself is highly anabolic.
The preservative benzyl alcohol has been associated with serious adverse events, including the "gasping syndrome", and death in pediatric patients. Although normal therapeutic doses of this product ordinarily deliver amounts of benzyl alcohol that are substantially lower than those reported in association with the "gasping syndrome", the minimum amount of benzyl alcohol at which toxicity may occur is not known. The risk of benzyl alcohol toxicity depends on the quantity administered and the liver and kidneys' capacity to detoxify the chemical. Premature and low-birth weight infants may be more likely to develop toxicity.
Testosterone, like many anabolic steroids, was classified as a controlled substance in 1991. Testosterone is administered parenterally in normal and delayed-release (depot) forms. In September 1995, the FDA approved testosterone transdermal patches (Androderm), and many transdermal forms and brands are now available including implants, gels, and topical solutions. A testosterone buccal system, Striant, was FDA-approved in July 2003; Striant is a mucoadhesive product that adheres to the buccal mucosa and provides a controlled and sustained release of testosterone. In May 2014, the FDA approved an intranasal gel formulation of testosterone (Natesto). A transdermal patch (Intrinsa) for hormone replacement in women is under investigation; the daily dosages used in women are much lower than for products used in males. The FDA refused approval for Intrinsa in 2004 stating that more data regarding safety, especially in relation to cardiovascular and breast health, were required.